| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|---|
Phase N/A 1
2 3 4 Trials | | 0 | 9182736455463728190 |
|---|
| | | | |
|---|
| | | | |
|---|
| | | | |
|---|
| Esmya (ulipristal acetate) / ASKA Pharma, Gedeon Richter, AbbVie, Perrigo Company | | | |
|---|
| | |
|---|
| | |
|---|
| | | | |
|---|
| | | | |
|---|
| Lysodren (mitotane) / Perrigo Company | | | |
|---|
| | |
|---|
| | |
|---|
| | | | |
|---|
| | | | |
|---|
| Metopirone (metyrapone) / Perrigo Company | | | |
|---|
| | |
|---|
| | |
|---|
| | | | |
|---|
| | | | |
|---|
| bapineuzumab (AAB-001) / Pfizer, J&J, Perrigo Company | | | |
|---|
| | |
|---|
| | |
|---|
| | | | |
|---|
| | | | |
|---|
| vanutide cridificar (PF-236806) / J&J, Perrigo Company, Pfizer | | | |
|---|
| | |
|---|
| | |
|---|
| | | | |
|---|
| | | | |
|---|
| ELND 002 / Perrigo Company | | | |
|---|
| | |
|---|
| | |
|---|
| | | | |
|---|
| | | | |
|---|
| Gynazole-1 (butoconazole nitrate) / Perrigo Company, Covis Pharma | | | |
|---|
| | |
|---|
| | |
|---|
| | | | |
|---|
| | | | |
|---|
| Zelapar (selegiline orally disintegrating tablets) / Perrigo Company, Bausch Health | | | |
|---|
| | |
|---|
| | |
|---|
| | | | |
|---|
| | | | |
|---|
| Evamist (estradiol metered-dose transdermal system) / Acrux, Perrigo Company, Covis Pharma | | | |
|---|
| | |
|---|
| | |
|---|
| | | | |
|---|
| | | | |
|---|
|
